Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Onyx and Warner-Lambert renew cell cycle regulation agreement

Jan. 16, 1998

Cancer gene therapy technology available for licensing from NIH

Jan. 16, 1998

Novel tumor vaccine technology described by U.S. researchers

Jan. 15, 1998

Pacific receives patent allowance for immune system stimulant

Jan. 15, 1998

New proto-oncogene inhibitor isolated from fungus by Schering-Plough

Jan. 15, 1998

Pharma Mar discovers new antitumor heptapeptide from Australian ascidian

Jan. 15, 1998

Indian researchers describe new anticancer agent

Jan. 14, 1998

Korean researchers discover new PLC and PI turnover inhibitor from fungal strain

Jan. 14, 1998

U.S. marketing application submitted for AD-32

Jan. 14, 1998

Photofrin enters phase III testing for new indication

Jan. 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...